Skip to content
Drug recall · FDA · Published May 22, 2019

Fresenius Kabi USA, LLC recalls Ondansetron Injection, USP, 40 mg / 20 mL, 20 mL vial, Rx Only, Fresenius Kabi USA, LLC, Lake Zurich, IL 60047, NDC

Fresenius Kabi recalls 40mg/20mL ondansetron injection vials due to failed impurities and degradation specifications. This may pose a risk of harmful substances in the medication.

🇺🇸 FDA recall #D-1386-2019DrugFresenius Kabi ›
Take action

Contact the company & request your remedy

Recalling firmFresenius Kabi USA, LLC3159 Staley Rd, N/A · Grand Island, NY 14072-2028
No email on file for this recall — reach the company by phone or its official page instead.No email on file — write to the address above instead.
✎ GovInfoNow plain-language explainer

What happened, in plain English

Fresenius Kabi is recalling 40 mg/20 mL ondansetron injection vials that may contain impurities or degrade improperly. This could lead to harmful substances in the medication if used. Read more at govinfonow.com/recall/38772-fresenius-kabi-ondansetron-injection-recall-impurities-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/38772-fresenius-kabi-ondansetron-injection-recall-impurities-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-1386-2019

Cite this page

“Fresenius Kabi Ondansetron Injection Recall: Impurities Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/38772-fresenius-kabi-ondansetron-injection-recall-impurities-risk. Based on FDA recall #D-1386-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1386-2019%22&limit=1).

Why it’s dangerous

The recall is due to failed impurities and degradation specifications, meaning the medication may contain harmful substances or break down in a way that could be unsafe for patients. This could lead to adverse effects if the medication is used as intended.

Who’s affected

Patients prescribed ondansetron injections for nausea or vomiting, particularly those using the specific vial lot numbers mentioned in the recall. Healthcare providers administering the medication are also at risk.

How to tell if you have this one

Check for the vial label with 'Ondansetron Injection, USP, 40 mg / 20 mL' and the lot number 6018699, which expires December 2021. The product is sold by Fresenius Kabi USA, LLC.

  • Brand
    Fresenius Kabi
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Verify the lot number on the vial label to see if it matches 6018699.

✎ GovInfoNow

Questions people ask

Is this product safe to use?

The recall indicates the product may contain impurities or degrade improperly, so it is not safe to use as intended.

What should I do if I have this product?

The official recall does not specify a remedy, so contact Fresenius Kabi USA, LLC for further instructions.

How can I confirm if I have the recalled product?

Check the vial label for the lot number 6018699 and expiration date of December 2021.

Take action

Contact Fresenius Kabi

We’ve drafted a message you can send Fresenius Kabi to request your refund or repair — edit it as you like.

Subject: Recall D-1386-2019 — Fresenius Kabi Fresenius Kabi

Hello,

I own a Fresenius Kabi that is covered by recall D-1386-2019 from Fresenius Kabi.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

Keep exploring

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Comments are reviewed before they appear. No links, ads, or personal attacks — those get removed.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1386-2019 (May 22, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1386-2019 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA